Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.3450 (-2.73%) ($10.3000 - $10.3450) on Mon. Jan. 30, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.74% (three month average) | RSI | 46 | Latest Price | $10.3450(-2.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.6% a day on average for past five trading days. | Weekly Trend | BCRX advances 2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(37%) XBI(31%) IBB(28%) SDY(27%) IFRA(25%) | Factors Impacting BCRX price | BCRX will decline at least -1.87% in a week (0% probabilities). VIXM(-16%) UUP(-10%) VXX(-7%) TBT(-2%) SMH(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.87% (StdDev 3.74%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $10.71 | 5 Day Moving Average | $10.71(-3.41%) | 10 Day Moving Average | $10.49(-1.38%) | 20 Day Moving Average | $10.71(-3.41%) | To recent high | -24.9% | To recent low | 3.5% | Market Cap | $1.825b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |